DS-1062a
DS1062-A-U202
Phase 2 small_molecule completed
Quick answer
DS-1062a for Non-small Cell Lung Cancer is a Phase 2 program (small_molecule) at Daiichi Sankyo with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Daiichi Sankyo
- Indication
- Non-small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed